Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 400 of 465 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/15/17
End: 06/01/18
Due: 06/01/19
Phase: N/A
Priority: Normal
Start: 01/22/25
End: 05/31/27
Due: 05/31/28
Phase: N/A
Priority: Normal
Start: 02/01/14
End: 12/01/16
Due: 12/01/17
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 10/31/25
Due: 10/31/26
Phase: N/A
Priority: Normal
Start: 06/01/13
End: 03/25/22
Due: 03/25/23
Phase: N/A
Priority: Normal
Start: 10/26/15
End: 09/20/17
Due: 09/20/18
Phase: N/A
Priority: Normal
Start: 11/28/17
End: 11/28/17
Due: 11/28/18
Phase: N/A
Priority: Normal
Start: 04/04/21
End: 06/07/22
Due: 06/07/23
Phase: N/A
Priority: Normal
Start: 08/01/10
End: 12/17/14
Due: 12/17/15
Phase: N/A
Priority: Normal
Start: 11/12/09
End: 07/27/18
Due: 07/27/19
Phase: N/A
Priority: Normal
Start: 05/31/25
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 10/01/24
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 11/11/19
End: 07/18/22
Due: 07/18/23
Phase: N/A
Priority: Normal
Start: 11/22/22
End: 11/22/22
Due: 11/22/23
Phase: N/A
Priority: Normal
Start: 09/01/99
End: 03/01/03
Due: 03/01/04
Phase: N/A
Priority: Normal
Start: 02/01/16
End: 12/16/16
Due: 12/16/17
Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase: N/A
Priority: Normal
Start: 03/30/15
End: 10/28/21
Due: 10/28/22
Phase: N/A
Priority: Normal
Start: 06/29/05
End: 11/01/11
Due: 11/01/12
Phase: N/A
Priority: Normal
Start: 02/01/17
End: 09/20/18
Due: 09/20/19
Phase: N/A
Priority: Normal
Start: 09/01/12
End: 03/01/15
Due: 03/01/16
Phase: N/A
Priority: Normal
Start: 04/09/13
End: 06/01/17
Due: 06/01/18
Phase: N/A
Priority: Normal
Start: 10/01/09
End: 01/16/13
Due: 01/16/14
Phase: N/A
Priority: Normal
Start: 06/06/23
End: 06/06/23
Due: 06/06/24
Phase: N/A
Priority: Normal
Start: 07/14/10
End: 08/30/18
Due: 08/30/19
Phase: N/A
Priority: Normal
Start: 10/21/20
End: 06/30/25
Due: 06/30/26